Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
weasel667's Profile
Displaying 1-50 of 142 result(s).
CYDY CytoDyn Inc
09/28/2025 11:47:12 PM
Reading all about those problems (d (8)
CYDY CytoDyn Inc
09/20/2025 10:28:15 AM
After 5 years of BP partnership tal (7)
CYDY CytoDyn Inc
08/09/2025 4:09:53 AM
Connections (networking), top knowl (2)
CYDY CytoDyn Inc
08/06/2025 10:25:44 AM
Hey guys, what's with all the crypt (9)
CYDY CytoDyn Inc
06/28/2025 8:18:31 AM
Does anybody know who BRIAN COURTER (4)
CYDY CytoDyn Inc
06/20/2025 6:37:02 AM
Well, as an experienced CYDY shareh (11)
CYDY CytoDyn Inc
09/24/2024 10:17:45 AM
Are there any known results from Re (3)
CYDY CytoDyn Inc
07/30/2024 9:40:23 AM
The European Medicines Agency has r (5)
CYDY CytoDyn Inc
01/11/2024 6:53:40 AM
Especially bad optics for potential (10)
CYDY CytoDyn Inc
01/08/2024 11:09:25 AM
There should be rule, which limits (6)
CYDY CytoDyn Inc
01/07/2024 4:36:04 PM
If so, then why did Antonio got the (5)
CYDY CytoDyn Inc
11/14/2023 7:49:37 AM
Where were those experts, when we f (6)
CYDY CytoDyn Inc
11/01/2023 2:17:04 AM
This makes absolute sense. After se (4)
CYDY CytoDyn Inc
10/31/2023 1:48:47 PM
The only comforting thing right now (5)
CYDY CytoDyn Inc
10/13/2023 6:47:25 AM
I just got an email from my broker, (2)
CYDY CytoDyn Inc
08/25/2023 4:22:13 AM
But isn't this a problem for Merck? (4)
CYDY CytoDyn Inc
08/11/2023 4:09:24 AM
I do not want to burst anyone's bub (7)
CYDY CytoDyn Inc
08/02/2023 12:50:18 AM
I cannot imagine a greater insult t (7)
CYDY CytoDyn Inc
07/28/2023 2:41:41 AM
Spurious? For me this sounds more a (5)
CYDY CytoDyn Inc
05/27/2023 11:15:03 AM
NASH is the Leading Cause of Hepato (1)
CYDY CytoDyn Inc
05/23/2023 8:33:16 AM
4:05: Now, with that being said, we (2)
CYDY CytoDyn Inc
05/23/2023 6:49:07 AM
I have a question which is riddelin (2)
CYDY CytoDyn Inc
04/18/2023 10:16:05 AM
I belive Bayer Vital GmbH (Regorafe (3)
CYDY CytoDyn Inc
04/17/2023 3:02:20 AM
This must be some old trial: Collab
CYDY CytoDyn Inc
04/17/2023 2:45:54 AM
Leronlimab i (3)
CYDY CytoDyn Inc
04/13/2023 2:57:46 PM
Didn't Nader always tell us that we (3)
CYDY CytoDyn Inc
04/12/2023 3:57:52 AM
What clarification does the FDA nee (2)
CYDY CytoDyn Inc
04/12/2023 2:34:28 AM
The FDA then responded back with a (2)
CYDY CytoDyn Inc
03/02/2023 8:06:25 AM
"Nothing wrong" in the context of t (1)
CYDY CytoDyn Inc
03/02/2023 7:27:57 AM
So this is an example of how critic (8)
CYDY CytoDyn Inc
03/02/2023 4:13:06 AM
I assume some longs just disconnect (3)
CYDY CytoDyn Inc
12/21/2022 8:07:19 AM
If I remeber correctly, in the HIV (2)
CYDY CytoDyn Inc
12/21/2022 7:52:43 AM
So you basically say, that if AMARE (2)
CYDY CytoDyn Inc
12/21/2022 6:02:58 AM
I do not belive so. First, Cytodyn (11)
CYDY CytoDyn Inc
12/20/2022 2:02:22 AM
I belive it was more like a drama a (2)
CYDY CytoDyn Inc
12/10/2022 2:44:11 PM
Yes look in the future but lets lea (2)
CYDY CytoDyn Inc
12/10/2022 2:30:53 PM
I do not know whats up with you obs (2)
CYDY CytoDyn Inc
12/10/2022 1:49:18 PM
All the data they delivered is eith (5)
CYDY CytoDyn Inc
12/10/2022 8:38:24 AM
I can only assume that Nader and Ke (3)
CYDY CytoDyn Inc
10/29/2022 7:12:48 AM
You mean like Kelly has done recent (4)
CYDY CytoDyn Inc
10/08/2022 3:13:12 AM
Kelly was/ is not a simple field pl (5)
CYDY CytoDyn Inc
10/08/2022 1:04:22 AM
I would like to keep Scott Kelly on (11)
CYDY CytoDyn Inc
09/23/2022 10:14:59 AM
You believing this kind of incentiv (5)
CYDY CytoDyn Inc
09/23/2022 8:30:27 AM
They same speculation was done with (3)
CYDY CytoDyn Inc
09/23/2022 8:12:41 AM
I know this was part of his compens (4)
CYDY CytoDyn Inc
09/23/2022 7:46:09 AM
Impress me first or DELIVER and the (1)
CYDY CytoDyn Inc
09/20/2022 8:19:16 AM
" Do a crappy job on a free-lance (3)
CYDY CytoDyn Inc
09/08/2022 4:46:27 AM
I really do think the FDA knows Ler (5)
CYDY CytoDyn Inc
06/27/2022 10:05:13 AM
As a long time CYDY masochist I gue (5)
CYDY CytoDyn Inc
06/23/2022 10:10:03 AM
So you say this is common practice
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Weebit Nano Achieves Significant Breakthrough with Test Chips
  • Celebrating Utimaco's Partnership with Microsoft and Its Success
  • Invest in the Future: FleetMining's XRP Cloud Mining Options
  • Luca Shaw Shines with Second Place at UCI Downhill World Cup
  • Firefly Aerospace Expands National Security with SciTec Deal
  • Firefly Aerospace Strengthens National Security Through SciTec Buy
  • Joe Rogan Discusses the Dangers of Wealth-Driven Mindsets
  • Promising Drug Trials Offer Hope for Friedreich's Ataxia Patients
  • Apple's Leadership Changes: Who Will Steer the Future Next?
  • Impact of Loneliness on Motor Decline in Parkinson's Disease
  • Investing Insights by Peter Lynch: Clarity is Key for Success
  • Warren Buffett's Insights on Choosing Business Partners Wisely
  • Alex Pereira Triumphs Over Ankalaev to Reclaim UFC Title Glory
  • Empowering Parkinson's Care: High-Intensity Cycling Benefits
  • Promising New Drug Offers Hope for Multiple System Atrophy
  • Understanding the Rosen Law Firm's Class Action on Soleno
  • CRRC EV Unveils Innovative Electric Buses for Urban Mobility
  • Transforming Mindset: The Key to a Successful Six-Figure Business
  • Understanding Your Rights: Jasper Therapeutics Class Action
  • Shenzhen Futian Fashion Day Celebrates Creativity in Paris
  • Exciting Phase 1 Results for ARV-102's Potential in Neurodegenerative Care
  • Innovative Cell Therapy Promises Hope for Parkinson's Patients
  • Invest in the Future: Why MandalaChain's Presale Matters
  • Escalating Threat: North Korean IT Workers Exploit Tech Sector
  • Celebrating the Return of Doctor Who with Christopher Eccleston
  • Texas Firefighter Faces Pensions Challenges Amid Financial Turmoil
  • StarKist Celebrates 75 Years of Chosin Few Veterans' Courage
  • Bitcoin Breaks New Ground Surpassing $125,000 Mark
  • Understanding Your Rights in the Fortinet Fraud Case
  • Important Class Action Deadline for Fly-E Group Investors
  • Sara Blakely's Journey: From $5,000 to Entrepreneurial Success
  • Shiba Inu’s Burn Rate Skyrockets: Key Factors to Watch
  • Understanding Eco-Friendly Veterinary Care: Insights and Benefits
  • Semler Scientific, Inc. Class Action Guidance for Investors
  • Understanding Year-Round Pest Control with Shane Blackwell
  • Essentials of Relocating to Grand Rapids for Newcomers
  • Understanding the Best Time to Purchase a Home with Neil Hummel
  • Essential Legal Advice for Fluor Corporation Shareholders
  • Silver's Climb: Price Surge Signals Potential Investment Boom
  • FBI Agent's Duty Ends Over Controversial Comey Arrest Plans
  • Transforming Urban Transit: CRRC EV's All-Electric Revolution
  • Goldman Sachs' CEO Predicts AI Will Boost Job Opportunities
  • Jack Dorsey's Insights on Social Media and Bitcoin's Future
  • Abivax's Recent Trial Results Showcase Promise for Ulcerative Colitis Treatment
  • Homeland Security's Response to Super Bowl Performer Controversy
  • Unlocking the Future: MandalaChain's Innovative Tokenomics
  • Perplexity's CEO Supports Revolutionary AI Tool for Finance
  • Amazing Deals on Top XPPen Drawing Tablets for Artists
  • Starlink's Unseen Growth: Connecting a Global Community
  • Jim Farley's Son Chooses Mechanic Career Over College Degree
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site